Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autologous non-myeloablative hematopoietic stem cell transplantation for diffuse cutaneous systemic sclerosis: identifying disease risk factors for toxicity and long-term outcomes in a prospective, single-arm trial.
Georges GE, Khanna D, Wener MH, Mei MG, Mayes MD, Simms RW, Sanchorawala V, Hosing C, Kafaja S, Pawarode A, Holmberg LA, Kolfenbach J, Furst DE, Sullivan KM, Huang S, Gooley T, Nash RA. Georges GE, et al. Among authors: hosing c. Arthritis Rheumatol. 2024 Dec 3. doi: 10.1002/art.43072. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 39624016
Corrigendum to 'Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation' [Transplantation and Cellular Therapy 29/3 (2023) 204-204].
Alkhunaizi M, Patel B, Bueno L, Bhan N, Ahmed T, Arain MH, Saliba R, Rondon G, Dickey BF, Bashoura L, Ost DE, Li L, Wang S, Shpall E, Champlin RE, Mehta R, Popat UR, Hosing C, Alousi AM, Sheshadri A. Alkhunaizi M, et al. Among authors: hosing c. Transplant Cell Ther. 2024 Nov 17:S2666-6367(24)00742-5. doi: 10.1016/j.jtct.2024.10.013. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39561968 No abstract available.
High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomas.
Ramdial J, Lin R, Thall PF, Valdez BC, Hosing C, Srour S, Popat U, Qazilbash M, Alousi A, Barnett M, Gulbis A, Shigle TL, Shpall EJ, Andersson BS, Nieto Y. Ramdial J, et al. Among authors: hosing c. Bone Marrow Transplant. 2024 Dec;59(12):1754-1762. doi: 10.1038/s41409-024-02394-0. Epub 2024 Sep 28. Bone Marrow Transplant. 2024. PMID: 39341929 Free PMC article.
Humoral Immunity and Antibody Responses against Diphtheria, Tetanus, and Pneumococcus after Immune Effector Cell Therapies: A Prospective Study.
Angelidakis G, Chemaly RF, Sahasrabhojane PV, Morado-Aramburo O, Jiang Y, Bhatti MM, Shpall E, Hosing C, Jain P, Mahadeo KM, Khawaja F, Elhajj P, Wargo JA, Jenq RR, Ajami NJ, Kebriaei P, Ariza-Heredia EJ. Angelidakis G, et al. Among authors: hosing c. Vaccines (Basel). 2024 Sep 19;12(9):1070. doi: 10.3390/vaccines12091070. Vaccines (Basel). 2024. PMID: 39340100 Free PMC article.
On the Way to Curing Advanced-Stage Mycosis Fungoides/Sézary Syndrome.
Purnak S, Hosing C, Dabaja B, Bassett RL, Huen A, Duvic M. Purnak S, et al. Among authors: hosing c. Clin Lymphoma Myeloma Leuk. 2024 Dec;24(12):827-836. doi: 10.1016/j.clml.2024.07.011. Epub 2024 Jul 14. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39107202
Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study.
Herrera AF, Zain J, Savage KJ, Feldman T, Brammer JE, Chen L, Puverel S, Popplewell L, Budde LE, Mei M, Hosing C, Nair R, Leslie L, Daniels S, Peters L, Forman S, Rosen S, Kwak L, Iyer SP. Herrera AF, et al. Among authors: hosing c. Lancet Haematol. 2024 Sep;11(9):e671-e681. doi: 10.1016/S2352-3026(24)00171-6. Epub 2024 Jul 24. Lancet Haematol. 2024. PMID: 39067464 Clinical Trial.
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis.
Malek AE, Al-Juhaishi T, Milton DR, Ramdial JL, Daher M, Olson AL, Srour SA, Alatrash G, Oran B, Mehta RS, Khouri IF, Bashir Q, Shah N, Ciurea SO, Rondon G, Maadani F, Hosing C, Marin D, Kebriaei P, Rezvani K, Nieto Y, Anderlini P, Alousi AM, Faisal MS, Qazilbash MH, Popat UR, Champlin RE, Shpall EJ, Mulanovich VE, Ahmed S. Malek AE, et al. Among authors: hosing c. Bone Marrow Transplant. 2024 May;59(5):699-704. doi: 10.1038/s41409-024-02238-x. Epub 2024 Feb 14. Bone Marrow Transplant. 2024. PMID: 38355908 No abstract available.
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
Ahmed S, Bashir Q, Bassett RL Jr, Ullah F, Aung F, Valdez BC, Alousi AM, Hosing C, Kebriaei P, Khouri I, Marin D, Nieto Y, Olson A, Oran B, Qazilbash MH, Rezvani K, Mehta R, Shpall EJ, Ciurea S, Andersson BS, Champlin RE, Popat UR. Ahmed S, et al. Among authors: hosing c. Am J Hematol. 2024 Apr;99(4):562-569. doi: 10.1002/ajh.27233. Epub 2024 Feb 5. Am J Hematol. 2024. PMID: 38314663 Clinical Trial.
308 results